Israel Englander’s Centessa Pharmaceuticals CNTA Stock Holding History

Israel Englander’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-69,000	Closed	-$2.74M	–	5927
2026 Q1	$2.74M	Buy	+69,000	New	+$1.76M	﹤0.01%	3558
2025 Q4	–	Sell	-50,000	Closed	-$1.21M	–	6065
2025 Q3	$1.21M	Buy	+50,000	New	+$889K	﹤0.01%	4479

Israel Englander's CNTA Position: Q2 2026 in Review

Israel Englander sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 722,121 shares — an estimated $28.7M sold.

Israel Englander first reported a position in CNTA in Q2 2021 and held it in 12 quarters. The position peaked at $46.8M in Q4 2025. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Israel Englander reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Israel Englander sold 722,121 Centessa Pharmaceuticals shares in Q2 2026, an estimated $28.7M.
Israel Englander first reported a position in Centessa Pharmaceuticals in Q2 2021 and held it in 12 quarters.
Israel Englander's Centessa Pharmaceuticals position peaked at $46.8M in Q4 2025.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.